A Case Study of Puerperal Group A Streptococcal Infection Complicated by Toxic Shock Syndrome

Abstract

Puerperal infection with group A streptococcus (GAS), Streptococcus pyogenes, is associated significant morbidity and mortality. When associated with toxic shock syndrome (TSS), mortality rates rise to approximately 50%. We present the case of a 32-year-old Para 2 reporting severe left distal lower extremity pain, fevers, and chills at 1 week following an uncomplicated vaginal delivery. The patient's clinical status rapidly decompensated to septic shock requiring transfer to the intensive care unit. She underwent anterior and lateral compartment fasciotomy of the left lower extremity for concerns of possible necrotizing soft tissue infection. Final blood cultures confirmed GAS infection with unclear primary source, though endometritis was favored. She required additional orthopaedic procedures including an arthroscopy with washout for contralateral septic arthritis and myositis before her discharge on hospital day 19. She obtained a near-full recovery complicated by poor wound healing and permanent left foot drop. While GAS remains a rare puerperal event, obstetricians should recall there is a 20-fold increased incidence among postpartum women. Progression to TSS is associated with very poor prognosis and hysterectomy is often necessary. Favorable outcomes in GAS with or without TTS hinge on astute clinical suspicion, aggressive fluid resuscitation, early antibiotic therapy, and source control.

Keywords

group A streptococcus - toxic shock syndrome - puerperal infection - sepsis - Streptococcus pyogenes

• References

• 1 Rimawi BH, Soper DE, Eschenbach DA. Group A streptococcal infections in obstetrics and gynecology. Clin Obstet Gynecol 2012; 55 (04) 864-874
• 2 Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5 (11) 685-694
• 3 Centers for Disease Control and Prevention. 2016. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus 2016. Available at: https://www.cdc.gov/abcs/reports-findings/survreports/gas16.html . Accessed December 10, 2019
• 4 Aronoff DM, Mulla ZD. Postpartum invasive group A streptococcal disease in the modern era. Infect Dis Obstet Gynecol 2008; 2008: 796892
• 5 Deutscher M, Lewis M, Zell ER, Taylor Jr. TH, Van Beneden C, Schrag S. ; Active Bacterial Core Surveillance Team. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis 2011; 53 (02) 114-123
• 6 O'Loughlin RE, Roberson A, Cieslak PR. , et al; Active Bacterial Core Surveillance Team. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45 (07) 853-862
• 7 Anderson BL. Puerperal group A streptococcal infection: beyond Semmelweis. Obstet Gynecol 2014; 123 (04) 874-882
• 8 Soper DE. Early recognition of serious infections in obstetrics and gynecology. Clin Obstet Gynecol 2012; 55 (04) 858-863
• 9 Dellinger RP, Levy MM, Rhodes A. , et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 (02) 580-637